Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD)

Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD)

<b>Background</b>: Cannabidiol (CBD) is an approved treatment for childhood epilepsies and a candidate treatment for several other CNS disorders. However, it has poor oral bioavailability. We investigated the effect of a novel lipid formulation on its absorption in humans and on its tiss...

Full description

Saved in:
Bibliographic Details
Main Authors: Edward Chesney, Ndabezinhle Mazibuko, Dominic Oliver, Amedeo Minichino, Ayşe Doğa Lamper, Lucy Chester, Thomas J. Reilly, Millie Lloyd, Matilda Kråkström, Alex M. Dickens, Matej Orešič, Eric Lynch, Gregory Stoloff, Mitul A. Mehta, Philip McGuire
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Pharmaceutics
Subjects:
CBD
cannabidiol
pharmacokinetics
bioavailability
formulation
Online Access:https://www.mdpi.com/1999-4923/16/12/1537
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1999-4923/16/12/1537

Similar Items